Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons.

Sleep is a natural process that preserves energy, facilitates development, and restores the nervous system in higher animals. Sleep loss resulting from physiological and pathological conditions exerts tremendous pressure on neuronal circuitry responsible for sleep-wake regulation. It is not yet clear how acute and chronic sleep loss modify neuronal activities and lead to adaptive changes in animals. Here, we show that acute and chronic prolonged wakefulness in mice induced by modafinil treatment produced long-term potentiation (LTP) of glutamatergic synapses on hypocretin/orexin neurons in the lateral hypothalamus, a well-established arousal/wake-promoting center. A similar potentiation of synaptic strength at glutamatergic synapses on hypocretin/orexin neurons was also seen when mice were sleep deprived for 4 hours by gentle handling. Blockade of dopamine D1 receptors attenuated prolonged wakefulness and synaptic plasticity in these neurons, suggesting that modafinil functions through activation of the dopamine system. Also, activation of the cAMP pathway was not able to further induce LTP at glutamatergic synapses in brain slices from mice treated with modafinil. These results indicate that synaptic plasticity due to prolonged wakefulness occurs in circuits responsible for arousal and may contribute to changes in the brain and body of animals experiencing sleep loss.

[1]  C. Economo SLEEP AS A PROBLEM OF LOCALIZATION , 1930 .

[2]  R A Levitt,et al.  Sleep Deprivation in the Rat , 1966, Science.

[3]  F. Bloom,et al.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  A. Rechtschaffen,et al.  Sleep deprivation in the rat: I. Conceptual issues. , 1989, Sleep.

[5]  A. Rechtschaffen,et al.  Sleep deprivation in the rat: X. Integration and discussion of the findings. , 2002, Sleep.

[6]  E. Kandel,et al.  Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. , 1993, Science.

[7]  E. Kandel,et al.  cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase , 1994, Cell.

[8]  R. Nicoll,et al.  Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. , 1994, Science.

[9]  G Tononi,et al.  Neuronal Gene Expression in the Waking State: A Role for the Locus Coeruleus , 1996, Science.

[10]  D. Edgar,et al.  Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[11]  M. Berger,et al.  Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation , 1998, Psychopharmacology.

[12]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[13]  G. Aston-Jones,et al.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system , 1999, The Journal of comparative neurology.

[14]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[15]  C. Saper,et al.  Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness , 2000, The Journal of Neuroscience.

[16]  E. Mignot,et al.  Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities , 2001, European Journal of Neuroscience.

[17]  I. Sora,et al.  Dopaminergic Role in Stimulant-Induced Wakefulness , 2001, The Journal of Neuroscience.

[18]  C. Saper,et al.  Fos Expression in Orexin Neurons Varies with Behavioral State , 2001, The Journal of Neuroscience.

[19]  E. Mignot,et al.  Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation , 2001, Neuroreport.

[20]  Mark A. Ungless,et al.  Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons , 2001, Nature.

[21]  Takeshi Sakurai,et al.  Hypocretin/Orexin Excites Hypocretin Neurons via a Local Glutamate Neuron—A Potential Mechanism for Orchestrating the Hypothalamic Arousal System , 2002, Neuron.

[22]  K. J. Parker,et al.  Circadian and Homeostatic Regulation of Hypocretin in a Primate Model: Implications for the Consolidation of Wakefulness , 2003, The Journal of Neuroscience.

[23]  R. Malenka,et al.  Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.

[24]  M. Bonnet,et al.  Clinical effects of sleep fragmentation versus sleep deprivation. , 2003, Sleep medicine reviews.

[25]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[26]  H. Myrick,et al.  Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[27]  J. Lisman,et al.  Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. , 2004, Journal of neurophysiology.

[28]  Takeshi Sakurai,et al.  Interaction between the Corticotropin-Releasing Factor System and Hypocretins (Orexins): A Novel Circuit Mediating Stress Response , 2004, The Journal of Neuroscience.

[29]  G. Tononi,et al.  Extensive and Divergent Effects of Sleep and Wakefulness on Brain Gene Expression , 2004, Neuron.

[30]  Mark J. Thomas,et al.  Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. G. Roseberry,et al.  Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin , 2004, Science.

[32]  J. Siegel Clues to the functions of mammalian sleep , 2005, Nature.

[33]  Jon T. Willie,et al.  Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates , 2005, Neuroscience.

[34]  Jerome M. Siegel,et al.  Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons , 2005, Neuron.

[35]  J. Costentin,et al.  The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice , 1994, Psychopharmacology.

[36]  O. Hassani,et al.  Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle , 2005, The Journal of Neuroscience.

[37]  M. Modirrousta,et al.  Orexin and MCH neurons express c‐Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors , 2005, The European journal of neuroscience.

[38]  A. Deutch,et al.  Dopaminergic regulation of orexin neurons , 2005, The European journal of neuroscience.

[39]  J. Sutcliffe,et al.  The hypocretins and sleep , 2005, The FEBS journal.

[40]  D. Dinges,et al.  Neurocognitive Consequences of Sleep Deprivation , 2005, Seminars in neurology.

[41]  T. Horvath,et al.  Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. , 2005, Cell metabolism.

[42]  T. Scammell,et al.  Afferents to the orexin neurons of the rat brain , 2006, The Journal of comparative neurology.

[43]  J. Ballon,et al.  A systematic review of modafinil: Potential clinical uses and mechanisms of action. , 2006, The Journal of clinical psychiatry.

[44]  C. Peyron,et al.  Gene expression in the rat brain during sleep deprivation and recovery sleep: an Affymetrix GeneChip® study , 2006, Neuroscience.

[45]  Jonathan R. Whitlock,et al.  Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.

[46]  T. Spencer,et al.  Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro , 2006, Journal of Pharmacology and Experimental Therapeutics.

[47]  Michelle E Quinlan,et al.  Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons , 2006, The Journal of Neuroscience.

[48]  H. Fields,et al.  Orexin A in the VTA Is Critical for the Induction of Synaptic Plasticity and Behavioral Sensitization to Cocaine , 2006, Neuron.

[49]  P. Henny,et al.  Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins , 2006, The Journal of comparative neurology.

[50]  Modafinil [2-[(Diphenylmethyl)sulfinyl]acetamide] and Circadian Rhythms in Syrian Hamsters: Assessment of the Chronobiotic Potential of a Novel Alerting Compound , 2006, Journal of Pharmacology and Experimental Therapeutics.

[51]  G. Tononi,et al.  Sleep function and synaptic homeostasis. , 2006, Sleep medicine reviews.

[52]  M. Picciotto,et al.  The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice , 2006, Psychopharmacology.

[53]  Gianluca Ficca,et al.  Increased spontaneous eye blink rate following prolonged wakefulness , 2007, Physiology & Behavior.

[54]  Takeshi Sakurai,et al.  The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness , 2007, Nature Reviews Neuroscience.

[55]  Xiao-Bing Gao,et al.  Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. , 2007, Journal of neurophysiology.